Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.

Islam MM, Topp L, Conigrave KM, White A, Reid SE, Grummett S, Haber PS, Day CA.

J Subst Abuse Treat. 2012 Dec;43(4):440-5. doi: 10.1016/j.jsat.2012.07.007. Epub 2012 Aug 29.

PMID:
22938915
2.

Hepatitis C: the end of the beginning and possibly the beginning of the end.

Alter HJ, Liang TJ.

Ann Intern Med. 2012 Feb 21;156(4):317-8. doi: 10.7326/0003-4819-156-4-201202210-00014. No abstract available.

3.

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.

Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM.

Ann Intern Med. 2012 Feb 21;156(4):263-70. doi: 10.7326/0003-4819-156-4-201202210-00378. Epub 2011 Nov 4.

PMID:
22056542
4.

Hepatitis C management by addiction medicine physicians: results from a national survey.

Litwin AH, Kunins HV, Berg KM, Federman AD, Heavner KK, Gourevitch MN, Arnsten JH.

J Subst Abuse Treat. 2007 Jul;33(1):99-105. Epub 2007 Mar 26.

5.

[Economic evaluation of health care program for hepatitis C virus antibody screening].

Ishizuka M.

Nihon Koshu Eisei Zasshi. 1999 Jun;46(6):447-65. Japanese.

PMID:
10513088
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk